SCHEMBL29923293

SCHEMBL29923293

COc1ccc2ccnc(Cl)c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.55
DYRK1A Q13627 3/20 0.51
CYP17A1 P05093 6/20 0.48
CYP11B1 P15538 6/20 0.48
CYP11B2 P19099 6/20 0.48
CYP3A4 P08684 3/20 0.48
CCR1 P32246 1/20 0.46
CCR5 P51681 1/20 0.46
CCR8 P51685 1/20 0.46
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 2/20 0.44
GFER P55789 1/20 0.44
LMNA P02545 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 1/20 0.43
APEX1 P27695 1/20 0.43
MAPK1 P28482 1/20 0.43
PMP22 Q01453 1/20 0.43
POLB P06746 1/20 0.43
PDE3B Q13370 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1526883 1.00 PLAU (0.55) PLAUDYRK1ACYP17A1CYP11B1CYP11B2
SCHEMBL303915 0.86 DYRK1A (0.55) PLAUDYRK1ACYP3A4CCR1CCR5
SCHEMBL13409731 0.81 LMNA (0.40) PLAUCYP3A4ALDH1A1LMNAKDM4E
SCHEMBL1871112 0.81 CYP3A4 (0.42) PLAUDYRK1ACYP17A1CYP11B1CYP11B2
SCHEMBL129972 0.80 PLAU (0.56) PLAUDYRK1ACYP3A4CCR1CCR5
SCHEMBL31521713 0.80 PLAU (0.56) PLAUDYRK1ACYP3A4CCR1CCR5
SCHEMBL1834564 0.79 PLAU (0.59) PLAUDYRK1ACCR1CCR5CCR8
SCHEMBL12055259 0.79 PLAU (0.59) PLAUCYP17A1CYP11B1CYP11B2CYP3A4
SCHEMBL21951884 0.79 PLAU (0.55) PLAUCYP17A1CYP11B1CYP11B2CYP3A4
SCHEMBL28068060 0.79 PLAU (0.55) PLAUCYP17A1CYP11B1CYP11B2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598533-A1 LACTATE ENHANCING COMPOUNDS AND USES THEREOF Gliapharm SA (CH) 2025-08-13 EP disclosed
WO-2024074436-A1 LACTATE ENHANCING COMPOUNDS AND USES THEREOF GLIAPHARM SA (CH) 2024-04-11 WO disclosed
EP-4055013-A1 WDR5 INHIBITORS AND MODULATORS Vanderbilt University (US) 2022-09-14 EP disclosed